Literature DB >> 12134006

Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology.

Himangi R Jayakar1, Michael A Whitt.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) is a multifunctional protein that is responsible for condensation of the ribonucleocapsid core during virus assembly and also plays a critical role in virus budding. The M protein is also responsible for most of the cytopathic effects (CPE) observed in infected cells. VSV CPE include inhibition of host gene expression, disablement of nucleocytoplasmic transport, and disruption of the host cytoskeleton, which results in rounding of infected cells. In this report, we show that the VSV M gene codes for two additional polypeptides, which we have named M2 and M3. These proteins are synthesized from downstream methionines in the same open reading frame as the M protein (which we refer to here as M1) and lack the first 32 (M2) or 50 (M3) amino acids of M1. Infection of cells with a recombinant virus that does not express M2 and M3 (M33,51A) resulted in a delay in cell rounding, but virus yield was not affected. Transient expression of M2 and M3 alone caused cell rounding similar to that with the full-length M1 protein, suggesting that the cell-rounding function of the M protein does not require the N-terminal 50 amino acids. To determine if M2 and M3 were sufficient for VSV-mediated CPE, both M2 and M3 were expressed from a separate cistron in a VSV mutant background that readily establishes persistent infections and that normally lacks CPE. Infection of cells with the recombinant virus that expressed M2 and M3 resulted in cell rounding indistinguishable from that with the wild-type recombinant virus. These results suggest that M2 and M3 are important for cell rounding and may play an important role in viral cytopathogenesis. To our knowledge, this is first report of the multiple coding capacities of a rhabdovirus matrix gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134006      PMCID: PMC155163          DOI: 10.1128/jvi.76.16.8011-8018.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98.

Authors:  J P Rodrigues; D Sitterlin; A Bachi; X Wu; M Wilm; M Carmo-Fonseca; E Izaurralde
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

3.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancios; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

5.  Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes.

Authors:  J M Petersen; L S Her; V Varvel; E Lund; J E Dahlberg
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus.

Authors:  K O Simon; P A Whitaker-Dowling; J S Youngner; C C Widnell
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

8.  A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding.

Authors:  R N Harty; J Paragas; M Sudol; P Palese
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.

Authors:  D S Lyles; M O McKenzie
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

10.  Normal replication of vesicular stomatitis virus without C proteins.

Authors:  E Kretzschmar; R Peluso; M J Schnell; M A Whitt; J K Rose
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

View more
  37 in total

1.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector.

Authors:  Yasuhiko Shinoda; Kuniko Hieda; Yoshio Koyanagi; Youichi Suzuki
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

5.  Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha.

Authors:  Jean Publicover; Elizabeth Ramsburg; Michael Robek; John K Rose
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.

Authors:  Melissa A Cobleigh; Clinton Bradfield; Yuanjie Liu; Anand Mehta; Michael D Robek
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein.

Authors:  Sibil Oksayan; Linda Wiltzer; Caitlin L Rowe; Danielle Blondel; David A Jans; Gregory W Moseley
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

9.  Genetic characterization of K13965, a strain of Oak Vale virus from Western Australia.

Authors:  Phenix-Lan Quan; David T Williams; Cheryl A Johansen; Komal Jain; Alexandra Petrosov; Sinead M Diviney; Alla Tashmukhamedova; Stephen K Hutchison; Robert B Tesh; John S Mackenzie; Thomas Briese; W Ian Lipkin
Journal:  Virus Res       Date:  2011-06-29       Impact factor: 3.303

10.  Tracking the Fate of Genetically Distinct Vesicular Stomatitis Virus Matrix Proteins Highlights the Role for Late Domains in Assembly.

Authors:  Timothy K Soh; Sean P J Whelan
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.